Goldman Hikes Obesity Drug Market Forecast As Oral GLP-1s Go Mass Market

Goldman Hikes Obesity Drug Market Forecast As Oral GLP-1s Go Mass Market The global weight-loss drug market is now expected to reach $114 billion by 2030, up from Goldman's prior $101 billion forecast, as analysts cite faster adoption of oral obesity pills, stronger demand outside the U.S., and improved affordability that is expanding the patient pool. Goldman analysts led by Asad Haider and James Quigley laid out four main drivers behind the upgraded 2030 anti-obesity drug TAM fo...